Literature DB >> 21039755

Voluntary exercise does not affect stress-induced tachycardia, but improves resistance to cardiac arrhythmias in rats.

Mirza I Beig1, Robin Callister, David A Saint, Eugene Bondarenko, Frederick R Walker, Trevor A Day, Eugene Nalivaiko.   

Abstract

1. It is currently unknown whether long-term voluntary exercise has enduring cardioprotective effects in animal models. 2. The present study was conducted in three groups of rats: (i) sedentary controls (n = 6); (ii) 24 h runners (n = 8; unlimited access to running wheels); and (iii) 2 h runners (n = 8; access to running wheels limited to 2 h daily). After termination of the 6 week exercise protocol, all rats were implanted with the telemetric electrocardiogram transmitters and were studied 1 week later. 3. Resting heart rate (HR) values in the control rats, 24 h runners and 2 h runners were 372 ± 7, 361 ± 9 and 298 ± 5 b.p.m., respectively (P < 0.05 for 2 h runners vs controls). The high-frequency spectral power in the control rats, 24 h runners and 2 h runners was 3.9 ± 0.2, 4.3 ± 0.3 and 5.3 ± 0.3 s², respectively (P < 0.05 for 2 h runners vs controls), whereas intrinsic HR was 383 ± 3, 377 ± 2 and 346 ± 3 b.p.m., respectively (P < 0.001 for 2 h runners vs controls). Restraint stress provoked tachycardia of similar magnitude in all groups. 4. After completion of telemetric studies, haemodynamic indices and susceptibility to cardiac arrhythmias were assessed in anaesthetized animals, there were no major between-group differences in HR, arterial pressure, contractility indices or sensitivity to β-adrenoceptor stimulation (dobutamine) or blockade (atenolol). The effective refractory period in the control rats, 24 h runners and 2 h runners was 49 ± 2, 55 ± 2 and 60 ± 4 ms, respectively (P = 0.054 for 2 h runners vs controls). A significantly higher dose of aconitine was required to provoke ventricular arrhythmias in the 24 h and 2 h running groups compared with controls (489 ± 76, 505 ± 88 and 173 ± 33 μg, respectively; P < 0.05). 5. We conclude that, in rats, long-term voluntary exercise has enduring cardioprotective effects mediated at the level of both the central nervous system and the heart.
© 2010 The Authors. Clinical and Experimental Pharmacology and Physiology © 2010 Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21039755     DOI: 10.1111/j.1440-1681.2010.05456.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  5 in total

Review 1.  A systematic comparison of exercise training protocols on animal models of cardiovascular capacity.

Authors:  Rui Feng; Liyang Wang; Zhonguang Li; Rong Yang; Yu Liang; Yuting Sun; Qiuxia Yu; George Ghartey-Kwansah; Yanping Sun; Yajun Wu; Wei Zhang; Xin Zhou; Mengmeng Xu; Joseph Bryant; Guifang Yan; William Isaacs; Jianjie Ma; Xuehong Xu
Journal:  Life Sci       Date:  2018-12-03       Impact factor: 5.037

Review 2.  Advances in understanding mechanisms and therapeutic targets to treat comorbid depression and cardiovascular disease.

Authors:  Brittany S Pope; Susan K Wood
Journal:  Neurosci Biobehav Rev       Date:  2020-06-26       Impact factor: 8.989

3.  Methods for ECG evaluation of indicators of cardiac risk, and susceptibility to aconitine-induced arrhythmias in rats following status epilepticus.

Authors:  Steven L Bealer; Cameron S Metcalf; Jason G Little
Journal:  J Vis Exp       Date:  2011-04-05       Impact factor: 1.355

Review 4.  Vagal modulation of resting heart rate in rats: the role of stress, psychosocial factors, and physical exercise.

Authors:  Luca Carnevali; Andrea Sgoifo
Journal:  Front Physiol       Date:  2014-03-24       Impact factor: 4.566

5.  The effect of high intensity interval training on cardioprotection against ischemia-reperfusion injury in wistar rats.

Authors:  Mostafa Rahimi; Shahnaz Shekarforoush; Ali Reza Asgari; Ali Khoshbaten; Hamid Rajabi; Behzad Bazgir; Mohammad Taghi Mohammadi; Vahid Sobhani; Abolfazl Shakibaee
Journal:  EXCLI J       Date:  2015-02-20       Impact factor: 4.068

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.